PBE vs. IBRN ETF Comparison

Comparison of PowerShares Dynamic Biotech & Genome (PBE) to iShares Neuroscience and Healthcare ETF (IBRN)
PBE

PowerShares Dynamic Biotech & Genome

PBE Description

The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$69.56

Average Daily Volume

6,596

Number of Holdings *

30

* may have additional holdings in another (foreign) market
IBRN

iShares Neuroscience and Healthcare ETF

IBRN Description iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$26.50

Average Daily Volume

367

Number of Holdings *

9

* may have additional holdings in another (foreign) market
Performance
Period PBE IBRN
30 Days 2.96% -1.47%
60 Days -0.81% 5.71%
90 Days -2.51% 1.28%
12 Months 22.72% 26.59%
2 Overlapping Holdings
Symbol Grade Weight in PBE Weight in IBRN Overlap
CPRX C 3.0% 3.97% 3.0%
NBIX C 4.18% 3.61% 3.61%
PBE Overweight 28 Positions Relative to IBRN
Symbol Grade Weight
UTHR C 5.74%
ILMN D 5.64%
ALNY D 4.78%
AMGN D 4.7%
BIIB F 4.21%
XNCR B 3.88%
EXEL B 3.86%
TGTX B 3.78%
BMRN D 3.76%
MNKD C 3.7%
NTRA B 3.56%
REGN F 3.38%
INCY C 3.35%
VCYT B 3.28%
ACAD D 3.06%
BPMC C 2.91%
TECH D 2.89%
VCEL B 2.79%
OPK C 2.78%
RGEN D 2.76%
PTGX C 2.75%
QGEN D 2.59%
BCRX D 2.56%
HALO F 2.42%
COLL F 2.27%
CDNA D 1.92%
NVAX F 1.83%
MYGN F 1.61%
PBE Underweight 7 Positions Relative to IBRN
Symbol Grade Weight
BHVN D -4.87%
PTCT B -4.57%
ITCI C -4.16%
ARGX A -3.9%
XENE D -3.86%
AXNX C -3.69%
LBPH A -3.56%
Compare ETFs